nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An editor׳s considerations in publishing industry-sponsored studies
|
Droller, Michael J. |
|
2015 |
33 |
3 |
p. 149-154 6 p. |
artikel |
2 |
A primer on clinical trial design
|
Ellimoottil, Chad |
|
2015 |
33 |
3 |
p. 116-121 6 p. |
artikel |
3 |
A randomized controlled trial to investigate magnetic resonance imaging–targeted biopsy as an alternative diagnostic strategy to transrectal ultrasound–guided prostate biopsy in the diagnosis of prostate cancer
|
Kasivisvanathan, Veeru |
|
2015 |
33 |
3 |
p. 156-157 2 p. |
artikel |
4 |
A window into new drug development for urologic oncology. Part I: How bench-to-bedside research can result in approval
|
Haas, Gabriel P. |
|
2015 |
33 |
3 |
p. 115- 1 p. |
artikel |
5 |
BCG-refractory vs. BCG-relapsing non–muscle-invasive bladder cancer: A prospective cohort outcomes study
|
Herr, Harry W. |
|
2015 |
33 |
3 |
p. 108.e1-108.e4 1.078921E6 p. |
artikel |
6 |
Caval tumor thrombus volume influences outcomes in renal cell carcinoma with venous extension
|
Zargar-Shoshtari, Kamran |
|
2015 |
33 |
3 |
p. 112.e23-112.e29 1.11999888E31 p. |
artikel |
7 |
Clinical phenotypes associated with circulating tumor cell enumeration in metastatic castration–resistant prostate cancer
|
Bitting, Rhonda L. |
|
2015 |
33 |
3 |
p. 110.e1-110.e9 1.09999998901E11 p. |
artikel |
8 |
Early PSA level decline is an independent predictor of biochemical and clinical control for salvage postprostatectomy radiotherapy
|
Blanchard, Pierre |
|
2015 |
33 |
3 |
p. 108.e15-108.e20 1.0799892E22 p. |
artikel |
9 |
Editorial Board
|
|
|
2015 |
33 |
3 |
p. i- 1 p. |
artikel |
10 |
Exploring the 3 A׳s of cystectomy access to care for muscle-invasive bladder cancer
|
Spencer, Elysia Sophie |
|
2015 |
33 |
3 |
p. 105-107 3 p. |
artikel |
11 |
Expression profile of epithelial-mesenchymal transition markers in non–muscle-invasive urothelial carcinoma of the bladder: Correlation with intravesical recurrence following transurethral resection
|
Liu, Bing |
|
2015 |
33 |
3 |
p. 110.e11-110.e18 1.09999989E20 p. |
artikel |
12 |
Final analysis of a prospective trial on functional imaging for nodal staging in patients with prostate cancer at high risk for lymph node involvement
|
Van den Bergh, Laura |
|
2015 |
33 |
3 |
p. 109.e23-109.e31 1.0899999891E33 p. |
artikel |
13 |
Food and Drug Administration process for development and approval of drugs and radiopharmaceuticals: Treatments in urologic oncology
|
Ning, Yang-Min |
|
2015 |
33 |
3 |
p. 137-142 6 p. |
artikel |
14 |
Galectin-8 predicts postoperative recurrence of patients with localized T1 clear cell renal cell carcinoma
|
Liu, Yidong |
|
2015 |
33 |
3 |
p. 112.e1-112.e8 1.1199998881E10 p. |
artikel |
15 |
Income inequality and treatment of African American men with high-risk prostate cancer
|
Zattoni, Fabio |
|
2015 |
33 |
3 |
p. 155- 1 p. |
artikel |
16 |
Independent data monitoring committees: An update and overview
|
Sartor, Oliver |
|
2015 |
33 |
3 |
p. 143-148 6 p. |
artikel |
17 |
Magnetic resonance imaging–targeted vs. conventional transrectal ultrasound–guided prostate biopsy: Single-institution, matched cohort comparison
|
Kim, Eric H. |
|
2015 |
33 |
3 |
p. 109.e1-109.e6 1.08998911E8 p. |
artikel |
18 |
Masthead
|
|
|
2015 |
33 |
3 |
p. IFC- 1 p. |
artikel |
19 |
Measures of survival benefit in cancer drug development and their limitations
|
Etzioni, Ruth |
|
2015 |
33 |
3 |
p. 122-127 6 p. |
artikel |
20 |
Medical devices: US medical device regulation
|
Jarow, Jonathan P. |
|
2015 |
33 |
3 |
p. 128-132 5 p. |
artikel |
21 |
MK2206 potentiates cisplatin-induced cytotoxicity and apoptosis through an interaction of inactivated Akt signaling pathway
|
Sun, Dingqi |
|
2015 |
33 |
3 |
p. 111.e17-111.e26 1.10999999889E28 p. |
artikel |
22 |
Molecular profiling of ETS gene rearrangements in patients with prostate cancer registered in REDEEM clinical trial 1 Share senior authorship.
|
Palanisamy, Nallasivam |
|
2015 |
33 |
3 |
p. 108.e5-108.e13 1.079999989200001E15 p. |
artikel |
23 |
Multiparametric magnetic resonance imaging localizes established extracapsular extension of prostate cancer
|
Feng, Tom S. |
|
2015 |
33 |
3 |
p. 109.e15-109.e22 1.089999891E24 p. |
artikel |
24 |
Murine β-defensin-2 may regulate the effect of bacillus Calmette-Guérin (BCG) in normal mouse bladder
|
Kwon, Jong Kyou |
|
2015 |
33 |
3 |
p. 111.e9-111.e16 1.109999889E18 p. |
artikel |
25 |
Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma 1 Contributed equally.
|
Zhou, Jiancheng |
|
2015 |
33 |
3 |
p. 113.e9-113.e17 1.1299999887E19 p. |
artikel |
26 |
Preoperative predictors of malignancy and unfavorable pathology for clinical T1a tumors treated with partial nephrectomy: A multi-institutional analysis
|
Ball, Mark W. |
|
2015 |
33 |
3 |
p. 112.e9-112.e14 1.1199888E16 p. |
artikel |
27 |
Presurgical sunitinib reduces tumor size and may facilitate partial nephrectomy in patients with renal cell carcinoma
|
Lane, Brian R. |
|
2015 |
33 |
3 |
p. 112.e15-112.e21 1.11999888E23 p. |
artikel |
28 |
Regulation of biologic oncology products in the FDA׳s Center for Biologics Evaluation and Research
|
Bross, Peter F. |
|
2015 |
33 |
3 |
p. 133-136 4 p. |
artikel |
29 |
Regulatory T cells and TGF-β1 in clinically localized renal cell carcinoma: Comparison with age-matched healthy controls
|
Kim, Choung-Soo |
|
2015 |
33 |
3 |
p. 113.e19-113.e25 1.12999887E27 p. |
artikel |
30 |
Role of fibroblast growth factor in squamous cell carcinoma of the bladder: Prognostic biomarker and potential therapeutic target
|
Youssef, Ramy F. |
|
2015 |
33 |
3 |
p. 111.e1-111.e7 1.109998891E9 p. |
artikel |
31 |
Surgical margin length and location affect recurrence rates after robotic prostatectomy
|
Dev, Harveer S. |
|
2015 |
33 |
3 |
p. 109.e7-109.e13 1.089998910000001E15 p. |
artikel |
32 |
Table of Contents
|
|
|
2015 |
33 |
3 |
p. ii-iv nvt p. |
artikel |
33 |
TLR4- and TLR9-dependent effects on cytokines, cell viability, and invasion in human bladder cancer cells 1 These authors contributed equally to this work.
|
Olbert, Peter J. |
|
2015 |
33 |
3 |
p. 110.e19-110.e27 1.099999989E29 p. |
artikel |
34 |
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in patients with clear cell renal cell carcinoma
|
Minardi, Daniele |
|
2015 |
33 |
3 |
p. 113.e1-113.e7 1.129998871E9 p. |
artikel |